Description:
The U.S. Agency for International Development (USAID)-funded Health Policy Plus (HP+) project and Indonesia's National Team for the Acceleration of Poverty Reduction (TNP2K) conducted an analysis to explore specific questions - e.g., How have JKN policies affected the private sector? Has the private sector's responses expanded access to high-quality healthcare at an affordable cost? Do JKN processes support the private health sector remaining robust and continuing to invest and grow? This analysis focused specifically on JKN's impact on pharmaceutical and medical device companies and private hospitals. We reviewed whether new actors have joined the market following JKN implementation - especially in geographical areas that were not well-served previously - whether the private sector's products or services have diversified, and whether JKN has motivated healthy competition between companies and hospitals.